International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma

Step into the forefront of myeloma treatment with this latest publication from the International Myeloma Working Group immunotherapy committee. Discover the groundbreaking world of immunotherapy, where innovations like CAR T-cell therapy and bispecific antibodies are reshaping myeloma treatment. An expert panel provides exclusive insights and tailored recommendations, guiding the way to optimised patient care. Ready…

Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper

Explore the latest guidelines for Smouldering Myeloma care in the British Society for Haematology Good Practice Paper. Discover evidence-based recommendations, including clear patient support, tailored vaccination strategies, and more. For a comprehensive overview, access the full paper here.

 

Guidelines for the diagnosis and management of multiple myeloma 2013 – management and treatment

These updated guidelines, produced by the British Committee for Standards in Haematology (BCSH) and the UK Myeloma Forum, summarise a national consensus of the haematological community involved in the diagnosis and management of myeloma patients. They should be read in conjunction with the BCSH Guidelines on the supportive care of myeloma patients. Bird et al.…

Myeloma: diagnosis and management (Presentation and Diagnosis)

These guidelines, produced by the National Institute for Health and Care Excellence (NICE), set out new recommendations for the diagnosis, treatment and care of myeloma patients with the aim of providing consistently excellent patient-focused care within the NHS in England. Update information October 2018: Recommendations 1.8.13 to 1.8.17 were replaced by NICE’s guideline on venous thromboembolism in…